Zoetis Inc. (NYSE:ZTS) shares fell -0.45% in last trading session and ended the day at $41.83. ZTS Gross Margin is 64.00% and its has a return on assets of 6.70%. Zoetis Inc. (NYSE:ZTS) quarterly performance is -8.41%.
Zoetis Inc. (NYSE:ZTS) has declared a second quarter 2016 dividend payable to holders of the company’s common stock of $0.095 per share. The dividend is to be paid on Wednesday, June 1, 2016, to holders of record on Thursday, April 7, 2016.
Ocean Shore Holding Co. (NASDAQ:OSHC) ended the last trading day at $17.10. Company weekly volatility is calculated as 1.73% and price to cash ratio as 0.90. Ocean Shore Holding Co. (NASDAQ:OSHC) showed a weekly performance of 1.18%.
Ocean Shore Holding Co. (NASDAQ:OSHC) announced that its annual meeting of shareholders will be held at The Flander’s Hotel located at 719 East 11th Street, Ocean City, New Jersey on Wednesday, May 25, 2016 at 8:30 a.m.
On 19 February, Garrison Capital Inc. (NASDAQ:GARS) shares moved up 1.54% and was closed at $11.21. GARS EPS growth in last 5 year was 30.47%. Garrison Capital Inc. (NASDAQ:GARS) year to date (YTD) performance is -7.89%.
Garrison Capital Inc. (NASDAQ:GARS) announced that it plans to report financial results for the fourth quarter ended December 31, 2015 after the financial markets close on Wednesday, March 2, 2016.
Ignyta, Inc. (NASDAQ:RXDX) shares fell -2.17% in last trading session and ended the day at $7.20. RXDX has a return on assets of -51.30%. Ignyta, Inc. (NASDAQ:RXDX) quarterly performance is -41.42%.
Ignyta, Inc. (NASDAQ:RXDX) announced that it has issued inducement awards to three new non-executive employees. All of the awards were made on February 15, 2016 under Ignyta’s 2015 Employment Inducement Equity Incentive Award Plan (the “Inducement Plan”), which was adopted July 17, 2015 and provides for the granting of equity awards to new employees of Ignyta.
Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) caters to the Healthcare space. Its weekly performance is 5.76%. On the last day of trading company shares ended up at $2.94. Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) distance from 50-day simple moving average (SMA50) is -0.20%.
Eyegate Pharmaceuticals Inc (NASDAQ:EYEG)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a report issued on Monday, Analyst Ratings Network.com reports.
Leave a Reply